Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upexi (UPXI) Cash & Equivalents (2020 - 2025)

Upexi (UPXI) has disclosed Cash & Equivalents for 6 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 297.88% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 297.88% year-over-year, with the annual reading at $3.0 million for FY2025, 349.82% up from the prior year.
  • Cash & Equivalents hit $1.6 million in Q4 2025 for Upexi, down from $2.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $14.5 million in Q2 2021 to a low of $224318.0 in Q1 2024.
  • Historically, Cash & Equivalents has averaged $3.6 million across 5 years, with a median of $2.2 million in 2021.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 2460.84% in 2021 and later crashed 87.43% in 2023.
  • Year by year, Cash & Equivalents stood at $6.6 million in 2021, then crashed by 31.65% to $4.5 million in 2022, then crashed by 87.43% to $566677.0 in 2023, then fell by 28.29% to $406347.0 in 2024, then skyrocketed by 297.88% to $1.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for UPXI at $1.6 million in Q4 2025, $2.2 million in Q3 2025, and $3.0 million in Q2 2025.